Drug Database
OF

ofloxacin (ofloxacin, Ranbaxy / Zanocin OD)

✓ Approved

Ranbaxy Laboratories Limited · 小分子 · 小分子

什么是 ofloxacin?

ofloxacin 是一种小分子,由Ranbaxy Laboratories Limited研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名ofloxacin, Ranbaxy, Zanocin OD
公司Ranbaxy Laboratories Limited
药物类别小分子
给药途径Oral (PO)
状态Approved

治疗适应症

ofloxacin 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsSalmonellosis✓ Approved

相关研究文献

PubMedFood chemistry2026-11-17

Multi-functional carbon dots-integrated hydrogel for visual detection of ofloxacin or Cu2+ and meat preservation.

Han Yong Y, Luo Xiaoyu X, Li Chengqian C, Kang Shufang S et al.

Antibiotic residues, heavy-metal contamination, and microbial spoilage pose significant risks to human health and ecosystems. Herein, Portulaca oleracea-derived red fluorescent carbon dots (R-CDs) were developed as a trifunctional platform for rapid detection of ofloxacin (OFLX) and Cu2+, as well as effective meat preservation. Upon 365 nm excitation, the R-CDs exhibited dual emission at 484 and 672 nm, enabling ratiometric sensing (F484/F672) over a linear range of 0-200 μmol/L, with detection limits of 0.00220 μmol/L (OFLX) and 0.00350 μmol/L (Cu2+). Smartphone RGB analysis gave visual LODs of 0.265 and 0.120 μmol/L. Immobilized in an acrylamide/poly (vinyl alcohol) hydrogel, the R-CDs allowed naked-eye semi-quantitative screening of OFLX (LOD 2.63 μmol/L) and effectively preserved pork, showing only 12.82% weight loss, pH 5.48, and clear antibacterial activity on day 10, outperforming PE film. Recoveries ranged from 59.26 to 102.11% (RSD < 3.49%). This work offers a green, portable, integrated strategy for dual-target sensing and meat preservation.

PMID 43044400
阅读全文 →
PubMedEnvironmental science & technology2026-11-17

Dark Evolution of Oxalate-Derived Radicals Unlocks Sustainable Decontamination via Soil Component Interactions.

Dou Jibo J, Xu Ruoru R, Qiao Jiangpeng J, Zhang Xinyan X et al.

We report a previously unrecognized dark aerobic pathway for radical formation from low-molecular-weight organic acids (LMWOAs)─distinct from well-documented photogenerated routes─that drives efficient soil decontamination. In ten ofloxacin-spiked soils with varying properties, oxalic acid (OA) boosted 24 h ofloxacin degradation from 20% (without LMWOAs) to 79% (7.5 mM OA), outperforming equimolar malic and citric acids. The degradation kinetics are governed by LMWOA molecular configurations─specifically, fewer carboxyl groups and lower pKa1 values that enhance reactivity─and correlate with soil organic matter (SOM) and iron contents. By combining a newly developed in situ fluorescence detector with quenching experiments, we demonstrated that in four representative soils with contrasting SOM-Fe combinations, higher Fe promotes the yields of •OH, O2•-, 1O2, and COO•-, but the coexisting SOM acts as the primary quencher. Validation experiments using artificial sand-based model soils and theoretical calculations revealed that crystalline Fe minerals (e.g., hematite), rather than dissolved Fe ions, drive radical evolution: oxalate coordinates to surface hydroxyls as a bifunctional ligand bearing electron-withdrawing carboxylates and transferable α-H, forming unstable ≡Fe(III)-oxalate complexes that undergo heterolysis and subsequent radical chain reactions, efficiently generating reactive species. Our study expands the understanding of LMWOA-derived radical geochemistry and provides a basis for nature-based, low-cost soil remediation using naturally occurring organic acids.

PMID 43043244
阅读全文 →
PubMedFoods (Basel, Switzerland)2026-11-14

Dietary Exposure Assessment of Veterinary Drug Residues in Animal-Derived Foods: Results from the Sixth Chinese Total Diet Study.

Wei Yu Y, Ren Jun J, Zhang Chi C, Li Jingguang J et al.

The global emergence of antibiotic residues in food-producing animals has raised substantial public health concerns due to their accumulation in edible tissues and organs. This investigation, conducted under the Sixth Chinese Total Diet Study (TDS), utilized ultra-high-performance liquid chromatography-high-resolution mass spectrometry to examine 96 composite dietary samples (derived from 1461 commonly consumed items) for the presence of 25 veterinary drugs (VDs) spanning seven therapeutic categories. The overall detection rate was 22.0%, with eggs (30.3%) and meats (30.0%) showing the highest rates. Four regulated VDs (trimethoprim, ofloxacin, enrofloxacin, and sarafloxacin), total sulfonamides, and three prohibited VDs (metronidazole, metronidazole, and chloramphenicol) in 22 samples (22.9%) exceeded the maximum residue limit (MRL) in China. These MRL comparisons are for reference only, as the MRL applicable to raw tissues does not match the cooked food composite samples analyzed in this study. Descriptive comparison across the Fourth to Sixth TDSs showed numerical differences in quinolone and sulfonamide detection rates and concentrations, though these findings require cautious interpretation due to methodological differences. For prohibited VDs lacking acceptable daily intakes (ADIs), the threshold of toxicological concern screening indicated that metronidazole and dimetridazole exceeded the genotoxic threshold, suggesting the need for further evaluation and attention. Notably, despite the high enrofloxacin occurrences (100% in aquatic products, 79.2% in meat samples), the estimated daily intakes for authorized VDs remained below 10% of their ADIs, indicating low health risks under the current exposure conditions.

PMID 43027536
阅读全文 →
PubMedClinical and experimental vaccine research2026-11-13

Genomic and proteomic characterization of the attenuated Salmonella Gallinarum live vaccine strain SR2-N6.

Kim Nam-Hyung NH, Cho Sun-Hee SH, Choi Kang-Seuk KS, Kwon Hyuk-Joon HJ

The rough Salmonella Gallinarum strain SR2-N6 has been used as a live vaccine against fowl typhoid and paratyphoid. This study aimed to characterize genomic, proteomic, and phenotypic features associated with its attenuation and differentiation from virulent and vaccine strains. SR2-N6 was compared with its virulent parental strain SG002 using comparative genomic sequencing and 2-dimensional gel electrophoresis followed by mass spectrometry. Quinolone susceptibility and survival during prolonged cold exposure were evaluated. An rfaJ deletion derivative of SG9R, designated Safe 9R, was generated to investigate positive reactions in a Salmonella serogroup D O-antigen enzyme-linked immunosorbent assay. SR2-N6 harbored a 13-nucleotide deletion in rfaL that resulted in truncation of the O-antigen ligase, and the deletion remained detectable after 20 passages. The virulence genes spvB and spvC were not detected. A G81C substitution in the quinolone resistance-determining region of gyrA was associated with 16- and 8-fold increases in the minimum inhibitory concentrations of enrofloxacin and ofloxacin, respectively, compared with SG002. Proteomic analysis identified altered abundance of stress- and metabolism-associated proteins, including decreased Dps abundance. SR2-N6 showed reduced survival during prolonged cold exposure. No O-antigen enzyme-linked immunosorbent assay (ELISA)-positive responses were detected in SR2-N6-inoculated chickens, whereas positive reactions occurred after inoculation with SG9R and Safe 9R. SR2-N6 possesses multiple molecular and phenotypic characteristics associated with attenuation and differentiation, including a stable rfaL deletion, absence of spvB and spvC, and altered stress tolerance. Its lack of detectable O-antigen ELISA responses may facilitate compatibility with serological surveillance programs.

PMID 43022356
阅读全文 →
PubMedInfectious diseases and therapy2026-11-10

Saliva as an Alternative Matrix for Antibiotic Pharmacokinetics and Therapeutic Drug Monitoring: Current Evidence and Future Directions: A Narrative Review.

Wang Mao-Shui MS, Wei Dong-Yan DY, Zhang Zhong-Fa ZF

Saliva is an attractive alternative matrix for pharmacokinetic assessment and therapeutic drug monitoring (TDM) because it is non-invasive, readily repeatable and potentially suitable for decentralized sampling. However, salivary drug concentrations are influenced by protein binding, ionization, lipophilicity, salivary pH and flow, collection procedures, oral contamination and analytical performance, limiting simple extrapolation from plasma. This narrative review synthesizes mechanistic, bioanalytical, pharmacokinetic and clinical evidence on salivary monitoring of antibacterial agents, with particular attention to antituberculosis drugs and the distinction between correlation and clinically meaningful agreement. Evidence varies substantially among drug classes. Linezolid has the most developed evidence base, with studies supporting saliva-based exposure estimation, although individual agreement, external validation and prospective evaluation of saliva-guided dosing remain insufficient for routine plasma substitution. Levofloxacin shows potential primarily as a screening tool for subtarget systemic exposure in multidrug- or rifampicin-resistant tuberculosis, whereas pyrazinamide may permit semiquantitative exposure assessment. Evidence for ofloxacin, isoniazid, rifampicin, metronidazole and selected macrolides suggests pharmacokinetic associations but remains inadequate for reliable individualized dosing. In contrast, current data do not support routine salivary TDM for aminoglycosides, vancomycin, most β-lactams, tetracyclines, ciprofloxacin or moxifloxacin. Across the literature, small cohorts, heterogeneous sampling methods, inadequate analytical sensitivity, and reliance on correlation rather than agreement or prediction-error analyses remain major limitations. Saliva should therefore be considered a drug- and application-specific investigational matrix rather than a general substitute for plasma. Future translation requires standardized collection and assay validation, prospective pharmacokinetic qualification, external validation of predictive models and demonstration that saliva-based dosing decisions improve clinical outcomes.

PMID 43007396
阅读全文 →
PubMedRSC advances2026-11-04

Reactive molecular dynamics insights into oxidation-induced degradation of ofloxacin and toxicity assessment of its transformation products.

Rajabov Otamurot O, Abduvokhidov Davronjon D, Bogaerts Annemie A, Yusupov Maksudbek M

The persistence and bioactivity of fluoroquinolone antibiotics in aquatic environments pose significant ecological and public health risks. In this study, the degradation mechanisms of ofloxacin (OFX) upon oxidation, such as by cold atmospheric plasma (CAP) treatment, were investigated using reactive molecular dynamics simulations within the density functional tight-binding framework, and the associated detoxification behavior was evaluated using quantitative structure-activity relationship (QSAR)-based toxicity assessment. Atomic oxygen (O), a dominant CAP-generated reactive species, was employed as a model oxidant to elucidate molecular-scale transformation pathways. Two oxidation regimes, corresponding to low and high (plasma) oxidation doses, were examined: non-consecutive and consecutive O atom impacts. Non-consecutive oxidation primarily induces isolated hydroxylation and hydrogen abstraction events, resulting in limited structural disruption and minimal reduction in predicted toxicity. In contrast, consecutive O atom exposure triggers cumulative oxidation characterized by repeated hydroxylation, hydrogen abstraction, heterocyclic ring opening, molecular fragmentation, and in one of the five simulated sequences, defluorination. Cleavage of the C-F bond proceeds via an indirect, multistep mechanism involving electronic redistribution and structural relaxation. QSAR-based toxicity predictions reveal a progressive detoxification trend under consecutive oxidation: whereas early intermediates retain toxic and mutagenic characteristics, advanced-stage products exhibit markedly reduced acute aquatic toxicity, lower bioconcentration potential and, where predictable, suppressed mutagenicity. Where it occurs, defluorination eliminates the pharmacophoric functionality of OFX and facilitates subsequent oxidative fragmentation. These findings demonstrate that sustained oxidative exposure is essential for effective (plasma-driven) detoxification of fluoroquinolone antibiotics and provide atomistic insights for optimizing (plasma-based) advanced oxidation processes in wastewater treatment.

PMID 42979204
阅读全文 →

注册免费账户还可查看另外 8419 篇文献

免费注册查看全部文献 →

了解更多ofloxacin